Overview

A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016C" With "BR1016D" in Healthy Volunteers

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetic properties and safety of "BR1016C" and "BR1016D" in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd